How to boost clinical trial access and make patients health-empowered
September 17, 2024 | Activated Patient, Inclusion, Patient Participation, Patient-centricity, Pharma, clinical trials
Clinical research is becoming more patient-centric, but there’s still more that needs to be done to make clinical trials available to everyone. This could include wider participation.
How to increase patient participation
Pharmaceutical companies are working on overturning this statistic by designing and building trials that centre around participant needs. This includes greater patient involvement in trial design; more opportunities for treatment at home; fewer tests and assessments; and new technologies for support and monitoring.
However, it seems clinical trial participation is not for everyone. Could it be because a huge amount of trust, awareness and understanding is needed to become a clinical trial participant?
Where the ‘activated’ patient comes in
According to health researcher Judith Hibbard, activated patients, who are actively engaged in managing their health and advocating for themselves, are better equipped to handle health conditions and contribute to treatment decisions.
Although, it’s not always an equal starting point because not everyone will be at activated status. Because initiatives often engage with those who are already activated and have high levels of health literacy, The complexity of clinical trial information means that some patients defer decision-making to their doctors. It may not be on purpose, but this excludes many from potentially life-changing medicines.
Empower patients through clinical trials
This may be an opportunity for those in charge of clinical trials to take a leading role in helping patients to become activated, creating a push-pull that works in all directions. Consider clinical trial education and awareness resources developed with everyone in mind, helping to bridge the knowledge gap and supporting people to make informed decisions for their own health.
Shift towards community-inclusive trials
The industry is already beginning to shift towards more patient-centred clinical trial recruitment and providing trial information that speaks to all. But that’s just the start. Perhaps it’s time to bring whole communities into contact with the clinical research world instead, giving everyone an opportunity to share their opinions and ideas —, a chance to feel part of something bigger.
It might not be easy, but it will be worth it.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Clinical trial considerations: Why diversity matters…
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here’s why diversity matters…
Clinical trial considerations: Why digital matters…
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.
Clinical trials explained: Why imagery matters…
Recruiting patients for clinical trials is one of pharma’s greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the…
Clinical trials explained: Why health literacy matters…
Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take…
Clinical trials explained: Why iconography matters…
Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial…
Cuttsy+Cuttsy appoints Harriet Karia as Managing Director
Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.
Using generative AI in healthcare comms – our promise to our clients
It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing our promises, so that when…
Clinical trials explained: Why colour matters…
Colour can be used to emphasise mood, evoke emotions, and determine first impressions of a brand. Find how to use colour effectively in your next clinical trial campaign.
Clinical trials explained: Why branding matters…
With nearly a decade’s experience supporting clinical trials, find out why we think humanising trials through design is so important.
DPHARM2023 – Five key themes impacting clinical trials today
Throughout three fascinating days of conference, some key themes emerged that are impacting study teams and the effectiveness of their clinical trials on a daily basis.